Rebecca joined the firm in 1994, having graduated with an Honours Degree in Biochemistry from Bristol University, and became a Partner in 2002.
Type of clients and client work
Rebecca’s practice is focused on portfolio development for SME’s, drafting and prosecuting their patent applications as well as advising on related transactions and commercial strategy. She also handles contentious matters, defending granted rights in EPO proceedings and advising on infringement of those patents; on the other side of the fence, she advises on the monitoring and impact on her clients’ activities of third party rights.
Experience obtained through worldwide prosecution of numerous patent families enables Rebecca to advise in filing and examination strategies and draft specifications with multiple jurisdictions in mind.
Rebecca has been involved with innovations in the fields of pharmaceutical and veterinary science, agroscience, human and animal nutrition, cosmetics, microbiology and virology and research and analytical tools. More specifically, she has drafted and prosecuted patent applications for newly identified genes and proteins, for techniques of nucleic acid isolation, manipulation and characterisation, to novel medical uses of known compounds and developments in disease diagnosis, to wood preservative formulations, therapeutically relevant peptides, genetically modified microorganisms and modified viruses and stem cell technology.
Qualifications and Memberships
BSc Hons, Bristol University, Biochemistry including options in Molecular Genetics and Physiology, 1993
Rebecca was mentioned in the 2020 edition of The Legal 500 as a “key lawyer” of the firm.
Rebecca often receives high praise from her clients, such as the comment below from one of her Norwegian clients:
Again, thank you for your enthusiasm, comments and swift service during our finalizing discussions regarding (company X). I believe those last ‘turns’ in the discussion improved the final outcome quite a lot.”